Hot Stocks
Wednesday, March 23, 2016
AstraZeneca heart drug fails in key stroke trial
LONDON, March 23 (Reuters) - AstraZeneca said on Wednesday its blood-thinning drug Brilinta failed to help stroke patients as hoped in a major clinical trial, dealing a blow to a product viewed as an...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment